Comments
Loading...

GeneDx Holdings Analyst Ratings

WGSNASDAQ
Logo brought to you by Benzinga Data
Consensus Rating1
Buy
Highest Price Target1
$118.00
Lowest Price Target1
$45.00
Consensus Price Target1
$82.60

GeneDx Holdings Analyst Ratings and Price Targets | NASDAQ:WGS | Benzinga

GeneDx Holdings Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for GeneDx Holdings Corp from these most-recent analyst ratings.

Analyst Trends and Forecast
2
3
Oct 24
1
Jan
1
Feb
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.0
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Goldman Sachs
TD Cowen
Wells Fargo
Craig-Hallum
BTIG

1calculated from analyst ratings

Analyst Ratings for GeneDx Holdings

Buy NowGet Alert
02/19/2025Buy NowGoldman Sachs
Matthew Sykes26%
$70 → $80MaintainsNeutralGet Alert
01/07/2025Buy NowTD Cowen
Dan Brennan71%
$75 → $118MaintainsBuyGet Alert
10/30/2024Buy NowGoldman Sachs
Matthew Sykes26%
$54 → $70MaintainsNeutralGet Alert
10/30/2024Buy NowWells Fargo
Brandon Couillard70%
$34 → $75MaintainsEqual-WeightGet Alert
10/30/2024Buy NowCraig-Hallum
Bill Bonello70%
$70 → $95MaintainsBuyGet Alert
10/24/2024Buy NowCraig-Hallum
Bill Bonello70%
$46 → $70MaintainsBuyGet Alert
10/16/2024Buy NowGoldman Sachs
Matthew Sykes26%
$32 → $54MaintainsNeutralGet Alert
08/27/2024Buy NowWells Fargo
Brandon Couillard70%
→ $34Initiates → Equal-WeightGet Alert
07/31/2024Buy NowTD Cowen
Dan Brennan71%
$46 → $50MaintainsBuyGet Alert
07/31/2024Buy NowBTIG
Mark Massaro71%
$35 → $45MaintainsBuyGet Alert
07/31/2024Buy NowCraig-Hallum
Bill Bonello70%
$43 → $46MaintainsBuyGet Alert
07/31/2024Buy NowGoldman Sachs
Matthew Sykes26%
$28 → $32MaintainsNeutralGet Alert
07/17/2024Buy NowGoldman Sachs
Matthew Sykes26%
$12.5 → $28MaintainsNeutralGet Alert
07/10/2024Buy NowCraig-Hallum
Bill Bonello70%
→ $43Initiates → BuyGet Alert
06/26/2024Buy NowBTIG
Mark Massaro71%
$19 → $35MaintainsBuyGet Alert
04/30/2024Buy NowTD Cowen
Dan Brennan71%
$14 → $24MaintainsBuyGet Alert
04/30/2024Buy NowBTIG
Mark Massaro71%
$15 → $19MaintainsBuyGet Alert
04/22/2024Buy NowBTIG
Mark Massaro71%
$11 → $15MaintainsBuyGet Alert
04/15/2024Buy NowGoldman Sachs
Matthew Sykes26%
$6 → $11MaintainsNeutralGet Alert
11/01/2023Buy NowGoldman Sachs
Matthew Sykes26%
$7 → $6MaintainsNeutralGet Alert
08/09/2023Buy NowGoldman Sachs
Matthew Sykes26%
$8 → $7MaintainsNeutralGet Alert
07/24/2023Buy NowGoldman Sachs
Matthew Sykes26%
$9 → $8MaintainsNeutralGet Alert
07/21/2023Buy NowGoldman Sachs
Matthew Sykes26%
$9 → $8MaintainsNeutralGet Alert
05/15/2023Buy NowGoldman Sachs
Matthew Sykes26%
$33 → $9MaintainsNeutralGet Alert

FAQ

Q

What is the target price for GeneDx Holdings (WGS) stock?

A

The latest price target for GeneDx Holdings (NASDAQ:WGS) was reported by Goldman Sachs on February 19, 2025. The analyst firm set a price target for $80.00 expecting WGS to fall to within 12 months (a possible -8.35% downside). 19 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for GeneDx Holdings (WGS)?

A

The latest analyst rating for GeneDx Holdings (NASDAQ:WGS) was provided by Goldman Sachs, and GeneDx Holdings maintained their neutral rating.

Q

When was the last upgrade for GeneDx Holdings (WGS)?

A

There is no last upgrade for GeneDx Holdings

Q

When was the last downgrade for GeneDx Holdings (WGS)?

A

There is no last downgrade for GeneDx Holdings.

Q

When is the next analyst rating going to be posted or updated for GeneDx Holdings (WGS)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of GeneDx Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for GeneDx Holdings was filed on February 19, 2025 so you should expect the next rating to be made available sometime around February 19, 2026.

Q

Is the Analyst Rating GeneDx Holdings (WGS) correct?

A

While ratings are subjective and will change, the latest GeneDx Holdings (WGS) rating was a maintained with a price target of $70.00 to $80.00. The current price GeneDx Holdings (WGS) is trading at is $87.29, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch